CTNM — CONTINEUM THERAPEUTICS INC

Ownership history in Squarepoint Ops LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in CONTINEUM THERAPEUTICS INC (CTNM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2024 Q3)
Avg. % of fund
0.0%
First filed
2024 Q2
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 13,086 -76,328 -85.4% 0.00% $154K $11.75
2025 Q2 REDUCED 89,414 -41,613 -31.8% 0.00% $355K $3.97
2025 Q1 REDUCED 131,027 -86,212 -39.7% 0.00% $915K $6.98
2024 Q4 REDUCED 217,239 -132,761 -37.9% 0.00% $3.2M $14.65
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CTNM price (monthly, adj. close)

Other funds also holding CTNM

As of 2025 Q4 — sorted by position size

SECTORAL ASSET MANAGEMENT INC 3Y 7Y 7.34% Versant Venture Management, LLC 3Y 7Y 4.11% JOHNSON & JOHNSON 3Y 4.08% GREAT POINT PARTNERS LLC 3Y 7Y 2.96% Monashee Investment Management LLC 3Y 7Y 0.89% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 0.67% Commodore Capital LP 3Y 0.62% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 0.49% Longaeva Partners L.P. 0.45% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 0.38%
← Back to Squarepoint Ops LLC Holdings